AGC Biologics, a CDMO recently formed out of the integration of Asahi Glass Company Bioscience, Biomeva and CMC Biologics, said it will expand its headquarters in Bothell, Washington. The new 150,000-square-foot building complex will become part of the company’s current facility and will contain process development labs, corporate offices and room to expand AGC’s manufacturing capacity, the company said.